International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis

Международная распространенность, выявление и лечение факторов сердечно-сосудистого риска у амбулаторных пациентов с атеротромбозом
Peter W.F. Wilson, Philippe Gabríel Steg, Deepak L. Bhatt, E. Magnus Ohman, Shinya Goto, Alan T. Hirsch, Yasuo Ikeda, Joachim Röther, Jean-Louis Mas, Chiau-Suong Liau, Alain J. Richard
2006-01-10

REACH Registryatherothrombosiscardiovascular risk factorsevidence-based therapiesrisk factor control
CONTEXT: Atherothrombosis is the leading cause of cardiovascular morbidity and mortality around the globe. To date, no single international database has characterized the atherosclerosis risk factor profile or treatment intensity of individuals with atherothrombosis. OBJECTIVE: To determine whether atherosclerosis risk factor prevalence and treatment would demonstrate comparable patterns in many countries around the world. DESIGN, SETTING, AND PARTICIPANTS: The Reduction of Atherothrombosis for Continued Health (REACH) Registry collected data on atherosclerosis risk factors and treatment. A total of 67,888 patients aged 45 years or older from 5473 physician practices in 44 countries had either established arterial disease (coronary artery disease [CAD], n = 40,258; cerebrovascular disease, n = 18,843; peripheral arterial disease, n = 8273) or 3 or more risk factors for atherothrombosis (n = 12,389) between 2003 and 2004. MAIN OUTCOME MEASURES: Baseline prevalence of atherosclerosis risk factors, medication use, and degree of risk factor control. RESULTS: Atherothrombotic patients throughout the world had similar risk factor profiles: a high proportion with hypertension (81.8%), hypercholesterolemia (72.4%), and diabetes (44.3%). The prevalence of overweight (39.8%), obesity (26.6%), and morbid obesity (3.6%) were similar in most geographic locales, but was highest in North America (overweight: 37.1%, obese: 36.5%, and morbidly obese: 5.8%; P<.001 vs other regions). Patients were generally undertreated with statins (69.4% overall; range: 56.4% for cerebrovascular disease to 76.2% for CAD), antiplatelet agents (78.6% overall; range: 53.9% for > or =3 risk factors to 85.6% for CAD), and other evidence-based risk reduction therapies. Current tobacco use in patients with established vascular disease was substantial (14.4%). Undertreated hypertension (50.0% with elevated blood pressure at baseline), undiagnosed hyperglycemia (4.9%), and impaired fasting glucose (36.5% in those not known to be diabetic) were common. Among those with symptomatic atherothrombosis, 15.9% had symptomatic polyvascular disease. CONCLUSION: This large, international, contemporary database shows that classic cardiovascular risk factors are consistent and common but are largely undertreated and undercontrolled in many regions of the world.
1
Evidence-based prevention was suboptimal: statin use was 69.4% overall, antiplatelet use was 78.6%, and half had elevated blood pressure at baseline.
2
Overweight, obesity, and morbid obesity were most prevalent in North America, including obesity at 36.5% and morbid obesity at 5.8%.
3
Residual risk remained substantial, with 14.4% of patients with established vascular disease currently smoking, 4.9% having undiagnosed hyperglycemia, and 36.5% impaired fasting glucose.
4
The REACH Registry analyzed 67,888 outpatients from 44 countries with established atherothrombosis or at least three major risk factors.
5
Worldwide, patients showed similarly high prevalence of hypertension (81.8%), hypercholesterolemia (72.4%), and diabetes (44.3%).

Outpatients with established atherothrombotic arterial disease or at least three atherothrombosis risk factors across 44 countries

International prevalence, recognition, treatment intensity, and control of atherosclerosis risk factors

Publication Details
Publication Date
2006-01-10
Journal
Publisher
ISSN
Cited by
1653
Access Type
Author Information
Authors
Peter W.F. Wilson
Philippe Gabríel Steg
Deepak L. Bhatt
E. Magnus Ohman
Shinya Goto
Alan T. Hirsch
Yasuo Ikeda
Joachim Röther
Jean-Louis Mas
Chiau-Suong Liau
Alain J. Richard
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%